The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010)

2017-05-08

Bliss, J

Kernaghan, S

Fribbens, C

Stevenson, L

Morden, J

Snowdon, C

Macpherson, I

Wardley, A

Roylance, R

Baird, R

Other

The Institute of Cancer Research (Grant ID: Unspecified)

Clinical Trials & Statistics Unit

2017-05-08

TRIALS, 2017, 18

Publications Repository